
I am a classically trained virologist with a focus on molecular mechanisms of RNA virus pathogenesis. My career is dedicated to unraveling RNA virus:host relations and devising methods of exploiting them for cancer immunotherapy and vaccine design. My background is in translation regulation and mRNA metabolism, viral RNA sensing and innate immunity, and cancer immunology and immunotherapy. Basic mechanistic research in my laboratory is supporting an ambitious clinical translational research program with active multi-center clinical trials in several cancer indications.
Education and Training
- Postdoctoral Associate, Molecular Genetics & Microbiology, State University of New York, Stony Brook, 1996 - 1999
- Postdoctoral fellow, Molecular Genetics & Microbiology, State University of New York, Stony Brook, 1993 - 1996
- M.D., University of Hamburg (Germany), 1992
Grants
- Cell and Molecular Biology Training Program
- Pharmacological Sciences Training Grant
- PVSRIPO in melanoma
- Viral Oncology Training Grant
- Innate Antiviral Signals for Cancer Immunotherapy
- Identifying oncolytic viral therapy resistance mechanisms in brain tumors
- Translational Research in Surgical Oncology
- T32 UNC - Duke Immunotherapy Training Program
- The Role of CD155 in Leptomeningeal Dissemination and Oncolytic Virus Susceptibility in the Medulloblastoma Microenvironment
- Regional Oncolytic Poliovirus Immunotherapy for Breast Cancer
- Oncolytic Polovirus, Immunotoxin, and Checkpoint Inhibitor Therapy of Gliomas